不孕症和怀孕快速检测套组市场－全球产业规模、份额、趋势、机会、预测：按类型、检测类型、分销管道、地区和竞争格局划分，2021-2031年

全球快速不孕症和妊娠检测套组市场预计将从 2025 年的 21.9 亿美元增长到 2031 年的 34.8 亿美元，复合年增长率为 8.02%。

这些试剂盒作为诊断性免疫检测盒，用于对生殖激素（特别是人类绒毛膜促性腺激素分泌和黄体激素）进行定性分析，旨在确认怀孕或识别排卵。该领域的成长受到妇科疾病发病率上升以及医疗模式转向分散化策略的推动，后者需要便捷即时的诊断工具。此外，全球孕产妇年龄的增长趋势也促使消费者倾向于居家检测而非前往医疗机构，从而维持了市场需求并推动了生产商的财务成长。

然而，严格的法规结构阻碍了市场发展，导致遵循成本增加，产品核可时间延长。製造商面临遵守复杂检验程序以确保设备准确性的挑战，这往往会延缓关键地区的商业化。根据欧洲医疗技术协会（MedTech Europe）预测，到2025年，体外诊断试剂製造商预计用于维护和重新认证以满足不断变化的合规标准的支出将增加70%。这一沉重的财务负担是创新者面临的主要障碍，并限制了整体市场流动性。

市场驱动因素

生育年龄延迟和人口老化的趋势是推动市场扩张的主要动力。随着女性优先考虑职涯发展并选择延后生育，自然受孕的几率降低，对精准排卵週期追踪和早期怀孕检测系统的需求也随之增加。这种转变导致人们更加依赖家用诊断试剂盒，以最大限度地提高在有限的排卵期内受孕的几率。根据美国疾病管制与预防中心 (CDC) 于 2025 年 6 月发布的报告《美国初产妇平均年龄趋势 (2016-2023)》，初产妇的平均年龄达到了创纪录的 27.5 岁，凸显了生育模式的改变。此外，大量针对意外怀孕的检测也为相关业务带来了可观的收入。根据联合国人口基金的说法，到 2025 年，约有 32% 的女性将经历意外怀孕，这保证了对意外怀孕快速诊断的稳定需求。

同时，数位技术的引入和智慧型手机相容检测功能的出现正在推动销售成长。製造商们正致力于创新，用数位显示器取代传统的类比显示屏，以提供更清晰的结果，并可透过蓝牙连接追踪应用程式。这种技术整合满足了消费者对清晰度和个人化健康数据的需求，为品牌的高价策略提供了基础。例如，根据 Church & Dwight 公司于 2025 年 10 月发布的 2025 年第三季财报，该公司净销售额成长了 5.0%，部分原因是其先进的个人保健产品组合表现强劲。这些发展巩固了诊断设备在更广泛的数位健康管理生态系统中的地位。

市场挑战

严格的法规结构是全球快速不孕症和妊娠检测套组市场发展的主要障碍。由于这些试剂盒被归类为体外诊断医疗设备（IVD），製造商必须经过复杂的检验程序并提交严格的临床数据以证明其安全性和准确性。这些日益严格的合规要求造成了巨大的进入门槛，尤其对于中小企业而言，因为这些要求延长了产品上市时间并增加了研发成本。因此，用于获得监管核准的资金和资源往往会被挪用，直接阻碍创新检测技术的商业性化应用。

这些监管压力深刻影响企业在市场进入方面的策略选择，导致企业倾向于避免或推迟在核准进度不确定的地区推出产品。由此产生的摩擦限制了新产品的供应，并缩小了关键市场的商机。根据欧洲医疗技术协会（MedTech Europe）预测，到2024年，由于当前复杂的监管环境，主要製造商选择欧盟作为体外诊断新产品首发地的趋势将下降40%。产品上市数量的下降表明，合规方面的挑战正在直接阻碍市场流动性，并限制整个产业的成长。

市场趋势

多激素交叉流式检测技术的应用正在从根本上改变市场格局，它超越了简单的黄体生成素检测，提供全面的激素谱分析。製造商正在开发先进的试剂盒，能够同时定量检测孕酮代谢物（PdG）和雌激素，使用户不仅可以预测排卵，还能确认排卵。这项发展满足了消费者对详细内分泌资讯的需求，帮助他们应对复杂的生育难题，并有效地将家庭诊断与临床医学联繫起来。 2025年12月，Inito在一份题为「B轮资金筹措2,900万美元，拓展不孕症治疗以外的业务」的新闻稿中宣布，已获得2,900万美元融资，用于扩展其人工智慧驱动的抗体平台，该平台支援先进的多参数检测功能。

同时，随着相关人员将永续性发展置于优先地位，并努力减少一次性诊断试剂对环境的影响，向可生物降解和环保检测设计转型的趋势正在加速。各公司正在扩大无塑胶机壳的研发，并采用来源可靠的材料，以满足全球减少废弃物的标准，并吸引具有环保意识的消费者。这项战略调整涉及用可回收纤维取代传统的聚合物组件，同时保持检测的灵敏度和保质期。例如，First Response品牌的母公司Church & Dwight Co., Inc.在其2025年4月发布的《2024年永续发展报告》中披露，该公司已将其全球包装材料组合中原生塑胶的使用量减少了29%，这体现了其对材料创新的承诺。这也反映了整个产业为减少对生态系统的影响而采取的行动。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球不孕症与怀孕快速检测套组市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（快速验孕检测套组、不孕症检测套组）
  • 检测类型（LH尿液检查、FSH尿液检查、hCG血液检测、hCG尿液检查）
  • 分销通路（医院通路、零售通路、线上通路）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美快速不孕症与妊娠检测套组市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲快速不孕症与妊娠检测套组市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区不孕及妊娠快速检测套组市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东及非洲快速不孕及妊娠检测套组市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲快速不孕不育与妊娠检测套组市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球不孕症与妊娠快速检测套组市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Swiss Precision Diagnostic GmbH
• DCC Plc
• The Procter & Gamble Company
• Abbott Laboratories, Inc.
• QuidelOrtho Corporation
• bioMerieux SA
• Church & Dwight Co., Inc.
• Prestige Consumer Healthcare Inc.
• Geratherm Medical AG
• Biogenix Inc. Pvt. Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Fertility and Pregnancy Rapid Test Kits Market is projected to expand from a valuation of USD 2.19 Billion in 2025 to USD 3.48 Billion by 2031, reflecting a CAGR of 8.02%. These kits function as diagnostic immunoassays intended for the qualitative analysis of reproductive hormones, particularly human chorionic gonadotropin and luteinizing hormone, to either confirm pregnancy or pinpoint ovulation windows. Growth in this sector is underpinned by an increasing incidence of gynecological conditions and a strategic transition toward decentralized healthcare models that demand accessible, immediate diagnostic tools. Additionally, the global trend of increasing maternal age encourages consumers to prefer home-based testing options over clinical appointments, thereby sustaining demand and driving financial growth for manufacturers.

However, the market's progression is hindered by rigorous regulatory frameworks that escalate compliance expenses and extend product approval timelines. Manufacturers face the challenge of navigating intricate validation procedures to guarantee device precision, which often retards commercialization efforts in major regions. According to MedTech Europe, in 2025, in vitro diagnostic manufacturers indicated a forecasted 70% surge in expenditures related to maintenance and recertification to satisfy changing compliance norms. This significant financial obligation poses a major obstacle for innovators and limits the overall fluidity of the market.

Market Driver

The demographic trend toward delayed childbearing and advanced maternal age serves as a primary engine for market expansion. As women choose to postpone childbirth in favor of career advancement, the timeframe for natural conception decreases, creating a need for accurate ovulation tracking and early pregnancy detection systems. This shift fosters a greater dependence on home diagnostic kits to optimize the likelihood of conception during restricted fertile windows. According to the Centers for Disease Control and Prevention, June 2025, in the 'Trends in Mean Age of Mothers in the United States, 2016 to 2023' report, the average age of first-time mothers climbed to a historic peak of 27.5 years, highlighting this alteration in reproductive schedules. Furthermore, revenue streams are supported by the substantial volume of testing for unplanned pregnancies; according to the United Nations Population Fund, in 2025, roughly 32% of women reported experiencing an unintended pregnancy, guaranteeing steady demand for rapid diagnostics outside of planned conception.

Concurrently, the incorporation of digital and smartphone-enabled testing capabilities is propelling value sales. Manufacturers are innovating to supplant traditional analog lines with digital displays that provide clear results and Bluetooth connectivity to tracking applications. This technological integration satisfies consumer requests for clarity and personalized health data, enabling brands to justify premium pricing strategies. For instance, according to Church & Dwight Co., Inc., October 2025, in the 'Q3 2025 Results' report, the corporation declared a 5.0% rise in net sales, credited in part to the robust performance of its advanced personal care portfolio. These developments firmly situate diagnostic devices within the wider ecosystem of digital health management.

Market Challenge

The implementation of strict regulatory frameworks represents a major obstacle impeding the development of the Global Fertility and Pregnancy Rapid Test Kits Market. Because these kits are categorized as in vitro diagnostic (IVD) medical devices, manufacturers are compelled to undergo complicated validation procedures and present rigorous clinical data to verify safety and precision. These heightened compliance requirements establish significant entry barriers, especially for smaller companies, by prolonging time-to-market and increasing development expenditures. Consequently, the funds and resources necessary to obtain regulatory approval often redirect investment away from research and development, directly halting the commercial introduction of innovative testing technologies.

This regulatory pressure profoundly influences strategic choices concerning market entry, leading manufacturers to bypass or postpone product launches in territories characterized by uncertain approval schedules. The consequent friction limits the accessibility of new products and curtails revenue possibilities in critical markets. According to MedTech Europe, in 2024, the inclination to select the European Union as the initial launch location for new in vitro diagnostic products fell by 40% among major manufacturers due to the intricacies of the prevailing regulatory landscape. This reduction in product introductions illustrates how compliance challenges directly obstruct market fluidity and restrict the sector's overall growth.

Market Trends

The adoption of multi-hormone lateral flow assays is fundamentally transforming the market by expanding beyond simple luteinizing hormone detection to provide comprehensive hormonal mapping. Manufacturers are engineering advanced kits capable of simultaneously quantifying progesterone metabolites (PdG) and estrogen, which allows users to confirm ovulation rather than simply predicting it. This evolution meets the consumer desire for detailed endocrine information to address complex fertility challenges, effectively connecting home diagnostics with clinical healthcare. According to Inito, December 2025, in the 'Inito raises $29M to expand beyond fertility' press release, the firm obtained $29 million in Series B financing to expand its AI-driven antibody platform, which supports this sophisticated multi-parameter testing functionality.

At the same time, the shift toward biodegradable and eco-friendly test designs is accelerating as stakeholders emphasize sustainability to lessen the environmental burden of single-use diagnostics. Companies are increasingly developing plastic-free housings and using responsibly sourced materials to comply with global waste reduction standards, thereby attracting environmentally aware consumers. This strategic adjustment entails substituting conventional polymer parts with recyclable fibers while maintaining assay sensitivity and shelf-life. Illustrating this dedication to material innovation, according to Church & Dwight Co., Inc., April 2025, in the '2024 Sustainability Report', the parent entity of the First Response brand realized a 29% decrease in virgin plastic usage across its global packaging portfolio, mirroring the industry-wide movement toward reduced ecological impact.

Key Market Players

• Swiss Precision Diagnostic GmbH
• DCC Plc
• The Procter & Gamble Company
• Abbott Laboratories, Inc.
• QuidelOrtho Corporation
• bioMerieux SA
• Church & Dwight Co., Inc.
• Prestige Consumer Healthcare Inc.
• Geratherm Medical AG
• Biogenix Inc. Pvt. Ltd.

Report Scope

In this report, the Global Fertility and Pregnancy Rapid Test Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fertility and Pregnancy Rapid Test Kits Market, By Type

• Pregnancy Rapid Test Kits
• Fertility Rapid Test Kits

Fertility and Pregnancy Rapid Test Kits Market, By Test Type

• LH Urine
• FSH Urine
• hCG Blood
• hCG Urine

Fertility and Pregnancy Rapid Test Kits Market, By Distribution Channel

• Hospital Channel
• Retail Channel
• Online Channel

Fertility and Pregnancy Rapid Test Kits Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fertility and Pregnancy Rapid Test Kits Market.

Available Customizations:

Global Fertility and Pregnancy Rapid Test Kits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fertility and Pregnancy Rapid Test Kits Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Pregnancy Rapid Test Kits, Fertility Rapid Test Kits)
  • 5.2.2. By Test Type (LH Urine, FSH Urine, hCG Blood, hCG Urine)
  • 5.2.3. By Distribution Channel (Hospital Channel, Retail Channel, Online Channel)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Fertility and Pregnancy Rapid Test Kits Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Test Type
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Test Type
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Test Type
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Test Type
      • 6.3.3.2.3. By Distribution Channel

7. Europe Fertility and Pregnancy Rapid Test Kits Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Test Type
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Test Type
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Test Type
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Test Type
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Test Type
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Test Type
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Fertility and Pregnancy Rapid Test Kits Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Test Type
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Test Type
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Test Type
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Test Type
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Test Type
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Test Type
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Fertility and Pregnancy Rapid Test Kits Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Test Type
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Test Type
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Test Type
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Test Type
      • 9.3.3.2.3. By Distribution Channel

10. South America Fertility and Pregnancy Rapid Test Kits Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Test Type
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Test Type
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Test Type
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Fertility and Pregnancy Rapid Test Kits Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Test Type
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Fertility and Pregnancy Rapid Test Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Swiss Precision Diagnostic GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. DCC Plc
• 15.3. The Procter & Gamble Company
• 15.4. Abbott Laboratories, Inc.
• 15.5. QuidelOrtho Corporation
• 15.6. bioMerieux SA
• 15.7. Church & Dwight Co., Inc.
• 15.8. Prestige Consumer Healthcare Inc.
• 15.9. Geratherm Medical AG
• 15.10. Biogenix Inc. Pvt. Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer